Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease

Chansik An, Youn Ah Choi, Dongil Choi, Yong Han Paik, Sang Hoon Ahn, Myeong Jin Kim, Seung Woon Paik, Kwang Hyub Han, Mi Suk Park

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

BACKGROUND/AIMS: The goal of this study was to estimate the growth rate of hepatocellular carcinoma (HCC) and identify the host factors that significantly affect this rate.

METHODS: Patients with early-stage HCC (n=175) who underwent two or more serial dynamic imaging studies without any anticancer treatment at two tertiary care hospitals in Korea were identified. For each patient, the tumor volume doubling time (TVDT) of HCC was calculated by comparing tumor volumes between serial imaging studies. Clinical and laboratory data were obtained from the medical records of the patients.

RESULTS: The median TVDT was 85.7 days, with a range of 11 to 851.2 days. Multiple linear regression revealed that the initial tumor diameter (a tumor factor) and the etiology of chronic liver disease (a host factor) were significantly associated with the TVDT. The TVDT was shorter when the initial tumor diameter was smaller, and was shorter in HCC related to hepatitis B virus (HBV) infection than in HCC related to hepatitis C virus (HCV) infection (median, 76.8 days vs. 137.2 days; P=0.0234).

CONCLUSIONS: The etiology of chronic liver disease is a host factor that may significantly affect the growth rate of early-stage HCC, since HBV-associated HCC grows faster than HCV-associated HCC.

Original languageEnglish
Pages (from-to)279-286
Number of pages8
JournalClinical and Molecular Hepatology
Volume21
Issue number3
DOIs
Publication statusPublished - 2015 Sep 1

Fingerprint

Liver Diseases
Hepatocellular Carcinoma
Chronic Disease
Tumor Burden
Growth
Virus Diseases
Hepatitis B virus
Hepacivirus
Neoplasms
Tertiary Healthcare
Korea
Tertiary Care Centers
Medical Records
Linear Models

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Molecular Biology

Cite this

An, Chansik ; Choi, Youn Ah ; Choi, Dongil ; Paik, Yong Han ; Ahn, Sang Hoon ; Kim, Myeong Jin ; Paik, Seung Woon ; Han, Kwang Hyub ; Park, Mi Suk. / Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease. In: Clinical and Molecular Hepatology. 2015 ; Vol. 21, No. 3. pp. 279-286.
@article{9d8bfe24f5c24202ab8f19a97797aaec,
title = "Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease",
abstract = "BACKGROUND/AIMS: The goal of this study was to estimate the growth rate of hepatocellular carcinoma (HCC) and identify the host factors that significantly affect this rate.METHODS: Patients with early-stage HCC (n=175) who underwent two or more serial dynamic imaging studies without any anticancer treatment at two tertiary care hospitals in Korea were identified. For each patient, the tumor volume doubling time (TVDT) of HCC was calculated by comparing tumor volumes between serial imaging studies. Clinical and laboratory data were obtained from the medical records of the patients.RESULTS: The median TVDT was 85.7 days, with a range of 11 to 851.2 days. Multiple linear regression revealed that the initial tumor diameter (a tumor factor) and the etiology of chronic liver disease (a host factor) were significantly associated with the TVDT. The TVDT was shorter when the initial tumor diameter was smaller, and was shorter in HCC related to hepatitis B virus (HBV) infection than in HCC related to hepatitis C virus (HCV) infection (median, 76.8 days vs. 137.2 days; P=0.0234).CONCLUSIONS: The etiology of chronic liver disease is a host factor that may significantly affect the growth rate of early-stage HCC, since HBV-associated HCC grows faster than HCV-associated HCC.",
author = "Chansik An and Choi, {Youn Ah} and Dongil Choi and Paik, {Yong Han} and Ahn, {Sang Hoon} and Kim, {Myeong Jin} and Paik, {Seung Woon} and Han, {Kwang Hyub} and Park, {Mi Suk}",
year = "2015",
month = "9",
day = "1",
doi = "10.3350/cmh.2015.21.3.279",
language = "English",
volume = "21",
pages = "279--286",
journal = "Clinical and molecular hepatology",
issn = "2287-2728",
publisher = "Korean Association for the Study of the Liver",
number = "3",

}

Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease. / An, Chansik; Choi, Youn Ah; Choi, Dongil; Paik, Yong Han; Ahn, Sang Hoon; Kim, Myeong Jin; Paik, Seung Woon; Han, Kwang Hyub; Park, Mi Suk.

In: Clinical and Molecular Hepatology, Vol. 21, No. 3, 01.09.2015, p. 279-286.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease

AU - An, Chansik

AU - Choi, Youn Ah

AU - Choi, Dongil

AU - Paik, Yong Han

AU - Ahn, Sang Hoon

AU - Kim, Myeong Jin

AU - Paik, Seung Woon

AU - Han, Kwang Hyub

AU - Park, Mi Suk

PY - 2015/9/1

Y1 - 2015/9/1

N2 - BACKGROUND/AIMS: The goal of this study was to estimate the growth rate of hepatocellular carcinoma (HCC) and identify the host factors that significantly affect this rate.METHODS: Patients with early-stage HCC (n=175) who underwent two or more serial dynamic imaging studies without any anticancer treatment at two tertiary care hospitals in Korea were identified. For each patient, the tumor volume doubling time (TVDT) of HCC was calculated by comparing tumor volumes between serial imaging studies. Clinical and laboratory data were obtained from the medical records of the patients.RESULTS: The median TVDT was 85.7 days, with a range of 11 to 851.2 days. Multiple linear regression revealed that the initial tumor diameter (a tumor factor) and the etiology of chronic liver disease (a host factor) were significantly associated with the TVDT. The TVDT was shorter when the initial tumor diameter was smaller, and was shorter in HCC related to hepatitis B virus (HBV) infection than in HCC related to hepatitis C virus (HCV) infection (median, 76.8 days vs. 137.2 days; P=0.0234).CONCLUSIONS: The etiology of chronic liver disease is a host factor that may significantly affect the growth rate of early-stage HCC, since HBV-associated HCC grows faster than HCV-associated HCC.

AB - BACKGROUND/AIMS: The goal of this study was to estimate the growth rate of hepatocellular carcinoma (HCC) and identify the host factors that significantly affect this rate.METHODS: Patients with early-stage HCC (n=175) who underwent two or more serial dynamic imaging studies without any anticancer treatment at two tertiary care hospitals in Korea were identified. For each patient, the tumor volume doubling time (TVDT) of HCC was calculated by comparing tumor volumes between serial imaging studies. Clinical and laboratory data were obtained from the medical records of the patients.RESULTS: The median TVDT was 85.7 days, with a range of 11 to 851.2 days. Multiple linear regression revealed that the initial tumor diameter (a tumor factor) and the etiology of chronic liver disease (a host factor) were significantly associated with the TVDT. The TVDT was shorter when the initial tumor diameter was smaller, and was shorter in HCC related to hepatitis B virus (HBV) infection than in HCC related to hepatitis C virus (HCV) infection (median, 76.8 days vs. 137.2 days; P=0.0234).CONCLUSIONS: The etiology of chronic liver disease is a host factor that may significantly affect the growth rate of early-stage HCC, since HBV-associated HCC grows faster than HCV-associated HCC.

UR - http://www.scopus.com/inward/record.url?scp=85050579093&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050579093&partnerID=8YFLogxK

U2 - 10.3350/cmh.2015.21.3.279

DO - 10.3350/cmh.2015.21.3.279

M3 - Article

C2 - 26523271

AN - SCOPUS:85050579093

VL - 21

SP - 279

EP - 286

JO - Clinical and molecular hepatology

JF - Clinical and molecular hepatology

SN - 2287-2728

IS - 3

ER -